Global Cardiopulmonary Autotransfusion Systems Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 91

Report ID: 1138

Cardiopulmonary Autotransfusion System is a sophisticated device with an exceptionally effective design that provides autologous blood during surgical procedures. Autotransfusion is a process wherein a person receives their own blood for a transfusion, instead of banked allogenic (separate-donor) blood.
Autotransfusion involves the collection of blood before surgeries and its transfusion during cardiac. The increasing prevalence of cardiac diseases has led to rise in cardiac surgeries which has propelled the cardiopulmonary autotransfusion market globally. According to the American Heart Association, globally over 80 million people suffer from heart health problems. This is occurring due to change in life style of people and consumption of high amount of fats and sugar. The complication in allogenic blood transfusion which results in significant loss of blood during cardiac surgery has led to the rise in demand for cardiopulmonary autotransfusion systems. Beside that innovation in the autotransfusion system due to advancement in technology has also boosted the global market of cardiopulmonary autotransfusion devices. Lack of availability of skilled professional for operating cardiopulmonary autotransfusion devices can restrain the growth of this market.
The Americas will continue to lead the market during the forecast period and is expected to occupy more than 45% of the overall market. Much of the region’s growth can be attributed to the rise in cardiovascular diseases (CVDs) and the subsequent mortality cases. The surge in cardiac surgeries has accelerated the demand for cardiopulmonary autotransfusion systems among medical facilities as this offers safe and efficient blood transfusion. Factors such as increased investments in R&D to develop innovative products that are superior in design and use will positively influence the market growth in this region.
In 2018, the global Cardiopulmonary Autotransfusion Systems market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Cardiopulmonary Autotransfusion Systems status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cardiopulmonary Autotransfusion Systems development in United States, Europe and China.

The key players covered in this study
Advancis Surgical
Fresenius Kabi
Haemonetics
LivaNova
Medtronic
Terumo
Atrium Medical
Global Blood Resources
Redax
Sarstedt
Stryker

Market segment by Type, the product can be split into
Unwashed ATS
Washed ATS

Market segment by Application, split into
Heart Surgery
Great Organ Transplant Surgery
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Cardiopulmonary Autotransfusion Systems status, future forecast, growth opportunity, key market and key players.
To present the Cardiopulmonary Autotransfusion Systems development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Cardiopulmonary Autotransfusion Systems are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Cardiopulmonary Autotransfusion Systems Market Size Growth Rate by Type (2014-2025)
1.4.2 Unwashed ATS
1.4.3 Washed ATS
1.5 Market by Application
1.5.1 Global Cardiopulmonary Autotransfusion Systems Market Share by Application (2014-2025)
1.5.2 Heart Surgery
1.5.3 Great Organ Transplant Surgery
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Cardiopulmonary Autotransfusion Systems Market Size
2.2 Cardiopulmonary Autotransfusion Systems Growth Trends by Regions
2.2.1 Cardiopulmonary Autotransfusion Systems Market Size by Regions (2014-2025)
2.2.2 Cardiopulmonary Autotransfusion Systems Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Cardiopulmonary Autotransfusion Systems Market Size by Manufacturers
3.1.1 Global Cardiopulmonary Autotransfusion Systems Revenue by Manufacturers (2014-2019)
3.1.2 Global Cardiopulmonary Autotransfusion Systems Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Cardiopulmonary Autotransfusion Systems Market Concentration Ratio (CR5 and HHI)
3.2 Cardiopulmonary Autotransfusion Systems Key Players Head office and Area Served
3.3 Key Players Cardiopulmonary Autotransfusion Systems Product/Solution/Service
3.4 Date of Enter into Cardiopulmonary Autotransfusion Systems Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Cardiopulmonary Autotransfusion Systems Market Size by Type (2014-2019)
4.2 Global Cardiopulmonary Autotransfusion Systems Market Size by Application (2014-2019)

5 United States
5.1 United States Cardiopulmonary Autotransfusion Systems Market Size (2014-2019)
5.2 Cardiopulmonary Autotransfusion Systems Key Players in United States
5.3 United States Cardiopulmonary Autotransfusion Systems Market Size by Type
5.4 United States Cardiopulmonary Autotransfusion Systems Market Size by Application

6 Europe
6.1 Europe Cardiopulmonary Autotransfusion Systems Market Size (2014-2019)
6.2 Cardiopulmonary Autotransfusion Systems Key Players in Europe
6.3 Europe Cardiopulmonary Autotransfusion Systems Market Size by Type
6.4 Europe Cardiopulmonary Autotransfusion Systems Market Size by Application

7 China
7.1 China Cardiopulmonary Autotransfusion Systems Market Size (2014-2019)
7.2 Cardiopulmonary Autotransfusion Systems Key Players in China
7.3 China Cardiopulmonary Autotransfusion Systems Market Size by Type
7.4 China Cardiopulmonary Autotransfusion Systems Market Size by Application

8 Japan
8.1 Japan Cardiopulmonary Autotransfusion Systems Market Size (2014-2019)
8.2 Cardiopulmonary Autotransfusion Systems Key Players in Japan
8.3 Japan Cardiopulmonary Autotransfusion Systems Market Size by Type
8.4 Japan Cardiopulmonary Autotransfusion Systems Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Cardiopulmonary Autotransfusion Systems Market Size (2014-2019)
9.2 Cardiopulmonary Autotransfusion Systems Key Players in Southeast Asia
9.3 Southeast Asia Cardiopulmonary Autotransfusion Systems Market Size by Type
9.4 Southeast Asia Cardiopulmonary Autotransfusion Systems Market Size by Application

10 India
10.1 India Cardiopulmonary Autotransfusion Systems Market Size (2014-2019)
10.2 Cardiopulmonary Autotransfusion Systems Key Players in India
10.3 India Cardiopulmonary Autotransfusion Systems Market Size by Type
10.4 India Cardiopulmonary Autotransfusion Systems Market Size by Application

11 Central & South America
11.1 Central & South America Cardiopulmonary Autotransfusion Systems Market Size (2014-2019)
11.2 Cardiopulmonary Autotransfusion Systems Key Players in Central & South America
11.3 Central & South America Cardiopulmonary Autotransfusion Systems Market Size by Type
11.4 Central & South America Cardiopulmonary Autotransfusion Systems Market Size by Application

12 International Players Profiles
12.1 Advancis Surgical
12.1.1 Advancis Surgical Company Details
12.1.2 Company Description and Business Overview
12.1.3 Cardiopulmonary Autotransfusion Systems Introduction
12.1.4 Advancis Surgical Revenue in Cardiopulmonary Autotransfusion Systems Business (2014-2019)
12.1.5 Advancis Surgical Recent Development
12.2 Fresenius Kabi
12.2.1 Fresenius Kabi Company Details
12.2.2 Company Description and Business Overview
12.2.3 Cardiopulmonary Autotransfusion Systems Introduction
12.2.4 Fresenius Kabi Revenue in Cardiopulmonary Autotransfusion Systems Business (2014-2019)
12.2.5 Fresenius Kabi Recent Development
12.3 Haemonetics
12.3.1 Haemonetics Company Details
12.3.2 Company Description and Business Overview
12.3.3 Cardiopulmonary Autotransfusion Systems Introduction
12.3.4 Haemonetics Revenue in Cardiopulmonary Autotransfusion Systems Business (2014-2019)
12.3.5 Haemonetics Recent Development
12.4 LivaNova
12.4.1 LivaNova Company Details
12.4.2 Company Description and Business Overview
12.4.3 Cardiopulmonary Autotransfusion Systems Introduction
12.4.4 LivaNova Revenue in Cardiopulmonary Autotransfusion Systems Business (2014-2019)
12.4.5 LivaNova Recent Development
12.5 Medtronic
12.5.1 Medtronic Company Details
12.5.2 Company Description and Business Overview
12.5.3 Cardiopulmonary Autotransfusion Systems Introduction
12.5.4 Medtronic Revenue in Cardiopulmonary Autotransfusion Systems Business (2014-2019)
12.5.5 Medtronic Recent Development
12.6 Terumo
12.6.1 Terumo Company Details
12.6.2 Company Description and Business Overview
12.6.3 Cardiopulmonary Autotransfusion Systems Introduction
12.6.4 Terumo Revenue in Cardiopulmonary Autotransfusion Systems Business (2014-2019)
12.6.5 Terumo Recent Development
12.7 Atrium Medical
12.7.1 Atrium Medical Company Details
12.7.2 Company Description and Business Overview
12.7.3 Cardiopulmonary Autotransfusion Systems Introduction
12.7.4 Atrium Medical Revenue in Cardiopulmonary Autotransfusion Systems Business (2014-2019)
12.7.5 Atrium Medical Recent Development
12.8 Global Blood Resources
12.8.1 Global Blood Resources Company Details
12.8.2 Company Description and Business Overview
12.8.3 Cardiopulmonary Autotransfusion Systems Introduction
12.8.4 Global Blood Resources Revenue in Cardiopulmonary Autotransfusion Systems Business (2014-2019)
12.8.5 Global Blood Resources Recent Development
12.9 Redax
12.9.1 Redax Company Details
12.9.2 Company Description and Business Overview
12.9.3 Cardiopulmonary Autotransfusion Systems Introduction
12.9.4 Redax Revenue in Cardiopulmonary Autotransfusion Systems Business (2014-2019)
12.9.5 Redax Recent Development
12.10 Sarstedt
12.10.1 Sarstedt Company Details
12.10.2 Company Description and Business Overview
12.10.3 Cardiopulmonary Autotransfusion Systems Introduction
12.10.4 Sarstedt Revenue in Cardiopulmonary Autotransfusion Systems Business (2014-2019)
12.10.5 Sarstedt Recent Development
12.11 Stryker

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details